Browse by ["viewname_eprint_publisher" not defined]

B

Becker, J. C. and Ugurel, S. and Leiter-Stoppke, U. and Meier, F. and Gutzmer, R. and Haferkamp, S. and Zimmer, L. and Livingstone, E. and Eigentler, T. and Hauschild, A. and Kiecker, F. and Hassel, J. C. and Mohr, P. and Fluck, M. and Thomas, I. and Garzarolli, M. and Grimmelmann, I. and Drexler, K. and Eckhardt, S. and Schadendorf, D. (2022) Adjuvant immunotherapy with nivolumab (NIVO) versus observation in completely resected Merkel cell carcinoma (MCC): Disease-free survival (DFS) results from ADMEC-O, a randomized, open-label phase II trial. ANNALS OF ONCOLOGY, 33 (Suppl7). S903. ISSN 0923-7534, 1569-8041

Bergbreiter, Astrid and Jaeger, Teresa and Karle, Antje and Bitzinger, Diane and Ettl, Tobias and Spanier, Gerrit and Jaegle, Herbert and Neu, Reiner and Soeder, Yorick and Evert, Matthias and Reichert, Torsten E. and Berneburg, Mark and Brochhausen, Christoph and Schreml, Julia and Fliegauf, Manfred and Salzer, Ulrich and Redel, Andreas and Schreml, Stephan (2021) Recurrent necrotizing cellulitis, multi-organ autoimmune disease and humoral immunodeficiency due to a novel NFKB1 frameshift mutation. EUROPEAN JOURNAL OF MEDICAL GENETICS, 64 (3): 104144. ISSN 1769-7212, 1878-0849

G

Gutzmer, R. and Eigentler, T. and Mohr, P. and Weichenthal, M. and Duecker, P. and Gebhardt, C. and Goeppner, D. and Haferkamp, S. and Kaehler, K. and Meier, F. and Pfoehler, C. and Satzger, I. and Sickmann, T. and Sindrilaru, A. and Terheyden, P. and Ugurel, S. and Ulrich, J. and Utikal, J. and Weishaupt, C. and Schadendorf, D. (2020) Nivolumab (NIVO) monotherapy or combination therapy with ipilimumab (NIVO plus IPI) in advanced melanoma patients with brain metastases: Real-world evidence from the German non-interventional study NICO. In: ESMO Virtual Congress, SEP 19-OCT 18, 2020, ELECTR NETWORK.

Gutzmer, R. and Eigentler, T. and Mohr, P. and Weichenthal, M. and Dücker, P. and Gebhardt, C. and Göppner, D. and Grimmelmann, I. and Haferkamp, S. and Kähler, K. C. and Meier, F. and Pföhler, C. and Sickmann, T. and Sindrilaru, A. and Terheyden, P. and Ugurel, S. and Ulrich, J. and Utikal, J. and Weishaupt, C. and Schadendorf, D. (2021) Comparison of effectiveness and safety of nivolumab monotherapy or in combination therapy with ipilimumab in therapy-naive and pretreated patients with advanced melanoma within the German noninterventional study NICO. In: Congress of the European Society for Medical Oncology (ESMO), SEP 16 - 21, 2021, Virtuell.

H

Hebestreit, Helge and Lapstich, Anne-Marie and Brandstetter, Lilly and Krauth, Christian and Deckert, Juergen and Haas, Kirsten and Pfister, Lisa and Witt, Stefanie and Schippers, Christopher and Dieris-Hirche, Jan and Maisch, Tim and Tuescher, Oliver and Barlescu, Lavinia and Berger, Alexandra and Berneburg, Mark and Britz, Vanessa and Deibele, Anna and Graessner, Holm and Guendel, Harald and Heuft, Gereon and Luecke, Thomas and Mundlos, Christine and Quitmann, Julia and Rutsch, Frank and Schubert, Katharina and Schulz, Joerg Bernhard and Schweiger, Susann and Zeidler, Cornelia and Zeltner, Lena and de Zwaan, Martina and ZSE DUO Working Grp, (2023) Effect of the addition of a mental health specialist for evaluation of undiagnosed patients in centres for rare diseases (ZSE-DUO): a prospective, controlled trial with a two-phase cohort design. ECLINICALMEDICINE, 65: 102260. ISSN , 2589-5370

K

Kahler, K. C. and Hassel, J. C. and Ziemer, M. and Rutkowski, P. and Meier, F. and Flatz, L. and Gaudy-Marqueste, C. and Zimmer, L. and Santinami, M. and Russano, F. and von Wasielewski, I. and Eigentler, T. K. and Maio, M. and Zalaudek, I. and Haferkamp, Sebastian and Quaglino, P. and Welzel, J. and Rocken, C. and Enk, A. and Simon, C. and Switaj, T. and Garzarolli, M. and Amaral, T. and Malissen, N. and Livingstone, E. and Elia, G. and Covelli, A. and Lorizzo, K. and Neri, D. and Mulatto, S. and Parca, A. and Pizzichi, B. and Ascierto, P. A. and Garbe, C. and Robert, C. and Schadendorf, D. and Hauschild, A. (2025) Neoadjuvant intralesional targeted immunocytokines (daromun) in stage III melanoma. ANNALS OF ONCOLOGY, 36 (10). ISSN 0923-7534, 1569-8041

M

Meischl, T. and Balcar, L. and Park, Y. R. and Bucher, L. and Meier, P. and Suhr, Y. and Pomej, K. and Mandorfer, M. and Reiberger, T. and Trauner, M. and Scheiner, B. and Pinter, M. (2024) Anaemia is independently associated with mortality in patients with hepatocellular carcinoma. ESMO OPEN, 9 (6): 103593. ISSN 2059-7029

S

Schadendorf, D. and Hassel, J. C. and Fluck, M. and Eigentler, T. and Loquai, C. and Haferkamp, S. and Gutzmer, R. and Meier, F. and Mohr, P. and Hauschild, A. and Menzer, C. and Kiecker, F. and Dippel, E. and Simon, J-C. and Conrad, B. and Garbe, C. and Körner, S. and Becker, J. C. and Zimmer, L. and Livingstone, E. (2022) Adjuvant nivolumab (NIVO) alone or in combination with ipilimumab (IPI) versus placebo in stage IV melanoma with no evidence of disease (NED): Overall survival (OS) results of IMMUNED, a randomized, double-blind multi-center phase II DeCOG trial. ANNALS OF ONCOLOGY, 33 (Suppl7). S900. ISSN 0923-7534, 1569-8041